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Irisin was recently identified as muscle-derived hormone that increases energy expendi-
ture. Studies in normal weight and obese subjects reported an increased irisin expres-
sion following physical activity, although inconsistent results were observed. Increased
physical activity in a subgroup of patients with anorexia nervosa (AN) complicates
the course of the disease. Since irisin could account for differences in clinical out-
comes, we investigated irisin levels in anorexic patients with high and moderate physical
activity to evaluate whether irisin differs with increasing physical activity. Hospitalized
female anorexic patients (n= 39) were included. Plasma irisin measured by enzyme-
linked immunosorbent assay and locomotor activity were assessed at the same time.
Patients were separated into two groups (n=19/group; median excluded): moderate
and high activity (6331±423 vs. 13743±1047 steps/day, p<0.001). The groups did
not differ in body mass index (14.2± 0.4 vs. 15.0± 0.4 kg/m2), irisin levels (558.2±26.1
vs. 524.9±25.2 ng/ml), and body weight-adjusted resting energy expenditure (17.6±0.3
vs. 18.0±0.3 kcal/kg/day, p>0.05), whereas body weight-adjusted total energy expen-
diture (46.0±1.4 vs. 41.1±1.1 kcal/kg/day), metabolic equivalents (METs, 1.9±0.1 vs.
1.7±0.1 METs/day), body weight-adjusted exercise activity thermogenesis (1.8±0.5 vs.
0.6±0.3 kcal/kg/day), duration of exercise (18.6±4.7 vs. 6.2±3.1 min/day), and body
weight-adjusted non-exercise activity thermogenesis (21.6±1.0 vs. 18.8±0.8 kcal/kg/day)
were higher in the high activity compared to the moderate activity group (p<0.05). No
correlations were observed between irisin and activity parameters in the whole sample
(p>0.05). In conclusion, the current data do not support the concept of irisin being induced
by exercise, at least not under conditions of severely reduced body weight like AN.
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INTRODUCTION
Irisin is a recently identified muscle-derived hormone produced by
cleavage from fibronectin type III domain containing 5 (FNDC5)
(1). The expression of FNDC5 is induced by the peroxisome
proliferator-activated receptor γ (PPARγ) coactivator 1α (PGC-
1α) that has been demonstrated to play an important role in the
expression of uncoupling protein 1 (UCP1), a key factor of ther-
mogenesis in brown adipose tissue (2). Irisin drives the browning
of subcutaneous white adipose tissue by stimulating the expres-
sion of UCP1 in beige fat cells (1). These beige fat cells have been
shown to be a cell type distinct from white or brown fat cells
being located in white adipose tissue (3) and exhibiting properties
of brown adipose tissue which – for long thought to exist only
in newborns – was recently also detected in adult humans (4, 5)
and demonstrated to be activated in response to cold exposure
(4). Besides its occurrence in skeletal muscle, irisin was detected –
although in much smaller quantities – in several human tissues
containing smooth muscle as well as heart muscle, and organs
including liver, kidney, and lung (6). Additionally, this peptide is
also present in adipose tissue (7, 8) and rodent cerebellar Purkinje
cells (9). Lastly, irisin was detected in the circulation (1, 6, 10, 11)
with decreased levels in patients with type 2 diabetes mellitus (10).
In their initial study, Boström et al. described an increase of
circulating irisin levels following physical activity in mice and in
male subjects after a 10-week endurance exercise program (1). In
a subsequent study, elevated circulating irisin levels were observed
following acute exercise consisting of 80-m sprints, while this effect
was weakened after a 8-week sprint training program completed
by young healthy men (6). However, one study detected a mod-
est 30% higher FNDC5 mRNA expression only in a subgroup of
older male subjects after an endurance training program com-
pared to sedentary controls, whereas no changes were observed in
a large sample of younger adults (12). While data on an exercise-
dependent production of irisin in muscle and its secretion into the
circulation are inconsistent in humans, an association of plasma
irisin levels with body mass index (BMI) seems to be a robust
finding. Extending the results of a previous study that showed a
trend toward a correlation of circulating irisin with BMI in sub-
jects with a BMI range from 20 to 48 kg/m2 (6), we previously
reported a positive correlation of plasma irisin levels with BMI
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over a very broad spectrum of body weights with BMIs ranging
from 8 to 85 kg/m2 as well as positive associations with fat mass
(FM), fat-free mass (FFM), and body cell mass (BCM) (11). One
previous study on the association of irisin and energy expenditure
reported that irisin levels correlated with 24-h energy expenditure
measured by indirect calorimetry in overweight and obese post-
menopausal women only in a subgroup of subjects whose energy
expenditure was higher than predicted by an FFM-based equation
(13), whereas it did not hold true when the whole sample was
analyzed.
In light of these data, more research is needed in order to
characterize the regulation of irisin under conditions of differ-
ent activity patterns and to establish its possible role as a novel
muscle-derived and exercise-induced hormone. In contrast to its
potentially beneficial effect as health-promoting hormone in over-
weight or obese patients, the role as an exercise-induced and
energy-dissipating myokine might be an additional biological
mechanism explaining worse clinical prognosis and higher relapse
rates of hyperactive anorexic subjects. Furthermore, anorexia ner-
vosa (AN) might be viewed as a mirror image of obesity and
thus investigation of this disease likely contributes to the under-
standing of weight disorders in general. Therefore, in the present
cross-sectional study we investigated the relationship of circulat-
ing irisin levels with measures of physical activity and different
aspects of energy expenditure in anorexic patients, since subjects
suffering from AN are known to display very different activity pat-
terns encompassing a relevant subgroup of hyperactive in contrast
to moderately active patients (14–16).
SUBJECTS AND METHODS
SUBJECTS
We recruited 39 anorexic female inpatients at admission to their
treatment in the Division for General Internal and Psychoso-
matic Medicine at Charité – Universitätsmedizin Berlin. Inclusion
criteria were a BMI of<18 kg/m2 and fulfillment of ICD-10 (Inter-
national Statistical Classification of Diseases and Related Health
Problems of the World Health Organization, 10th revision) criteria
(17) for typical or atypical AN. Atypical AN is defined as a disorder
meeting some criteria of the typical form (BMI below 17.5 kg/m2,
self-induced weight loss, body image distortion, and endocrine
disorder most often reflected by secondary amenorrhea) without
fulfilling all key symptoms (17). The restricting subtype of AN
according to the fourth edition of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) differs from the purging
subtype by the absence of binge-eating or purging behavior such as
self-induced vomiting or misuse of appetite suppressants, thyroid
hormones or laxatives, diuretics, and enemas (18).
According to their locomotor activity, anorexic patients were
separated into two groups by dividing the patients at the median
step count resulting in a moderate activity and a high activ-
ity group (n= 19/group, one patient with the median value was
excluded). Additionally, since the restricting subtype was shown to
be associated with excessive exercise (19, 20), calculations were also
performed for three subgroups of AN: typical restricting, typical
purging, and atypical AN.
Patients with current pregnancy or psychotic disorders and an
age of<18 years were excluded. The investigations were conducted
according to the Declaration of Helsinki. All patients gave writ-
ten informed consent and the study was approved by the insti-
tutional ethics committee of the Charité – Universitätsmedizin
Berlin (protocol number: EA1/114/10).
LABORATORY ANALYSIS OF IRISIN PLASMA LEVELS
All blood samples were collected from a forearm vein between 7
and 8 a.m. after an overnight fast during the period of the data
collection on physical activity. Participants were allowed to drink
small amounts of water but were advised not to smoke or exercise
before blood withdrawal. The blood was collected in pre-cooled
EDTA tubes prepared with aprotinin (1.2 Trypsin Inhibitory Unit
per 1 ml blood; ICN Pharmaceuticals, Costa Mesa, CA, USA) for
peptidase inhibition. The tubes were placed back on ice imme-
diately after blood withdrawal and then centrifuged at 4°C for
10 min at 3000× g. Plasma was separated and stored at −80°C
until further processing. At the day of the measurement, sam-
ples were diluted 1:10 and irisin plasma levels were analyzed
using a commercial enzyme-linked immunosorbent assay (ELISA,
catalog # EK-067-16, Phoenix Pharmaceutical, Inc., Burlingame,
CA, USA). All samples were processed in one batch (intra-assay
variability <5%).
MEASUREMENTS AND CALCULATION OF ACTIVITY AND ENERGY
EXPENDITURE
Weight and height were assessed on the day of the blood col-
lection. Weight was measured to the nearest 0.1 kg and height
to the nearest 0.5 cm. The BMI was calculated as kilogram per
square meter. Physical activity data were continuously measured
for 3 days (Friday to Sunday) during inpatient treatment using
a portable armband device (SWA; SenseWear™ PRO3 armband;
BodyMedia, Inc., Pittsburgh, PA, USA). One day was included in
the data analysis if the minimum duration of data acquisition was
20 h and 30 min/day. Patients were not activity restricted during
the measurement. Activity displayed by individuals is suggested to
be affected only in part deliberately with a high predictive value of
the activity level under sedentary conditions for daily life activity
(21). Although activity patterns under conditions of hospitaliza-
tion might differ from those in daily life, activity habits are likely
to persist during inpatient treatment if activity is not restricted
due to a genetic influence on physical activity (22).
The SWA uses a multisensory array including sensors measur-
ing heat flux, galvanic skin response, skin temperature, near-body
ambient temperature, and a two-axis accelerometer. Step counts
were measured by the accelerometer and directly taken for analy-
ses. Obtained data were analyzed using a generalized proprietary
algorithm developed by the manufacturer (SenseWear™ Software,
Version 6.1, BodyMedia, Inc.) and prepared for statistical analysis.
Total energy expenditure (TEE) consists of resting energy
expenditure (REE), thermic effect of food (TEF), and activity
thermogenesis. Activity thermogenesis can be further separated
into the two components exercise-related activity thermogenesis
(EAT, deliberate physical exercise, sports) and non-exercise activ-
ity thermogenesis (NEAT, spontaneous daily physical activity)
(23). Energy expenditure of more than five metabolic equiva-
lents (METs) of a task (a physiological measure expressing the
energy cost of physical activities) was classified as EAT, whereas
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energy expenditure of up to five METs was classified as NEAT
adapting the findings of Ainsworth et al. (24) and as described
before by our group (25). While TEE, EAT, and duration of
exercise were directly received from the proprietary algorithms
of the SWA, NEAT was calculated according to the equation:
NEAT=TEE−TEF−REE− EAT. TEF was estimated as 10% of
TEE and calculated as TEE× 0.1 (26). REE, required for calcu-
lation of NEAT, was calculated using weight-/group-specific REE
prediction equations provided by Müller et al. (27) since REE
cannot be directly determined by the SWA.
STATISTICAL ANALYSIS
Distribution of the data was determined by using the Kolmogorov–
Smirnov test. Data are expressed as mean± SEM. Differences
between groups were calculated using the t -test. For the com-
parison of the subtypes of AN differences between groups were
calculated using one-way analysis of variance (ANOVA) followed
by Tukey post hoc test. Correlations were determined by Pear-
son’s or Spearman’s analysis depending on the distribution of
the data. Differences between groups were considered signifi-
cant when p< 0.05. All statistical analyses were conducted using
SigmaStat 3.1.
RESULTS
IRISIN PLASMA LEVELS DO NOT DEPEND ON ACTIVITY AND ENERGY
EXPENDITURE
Per definition, the moderate activity and the high activity group
differed significantly in the number of steps performed per day
(p< 0.001; Figure 1A). However, irisin plasma levels were not dif-
ferent between these two groups (p= 0.37; Figure 1B). Associated
with the higher activity, significant differences were observed for
METs per day (p= 0.03; Figure 1C) and body weight-adjusted TEE
(p= 0.009; Figure 1D) with higher values in the high compared
to the moderate activity group. No differences were detected for
body weight-adjusted REE (p= 0.38; Figure 1E), whereas dura-
tion of exercise (p= 0.03; Figure 1F) or body weight-adjusted EAT
(p= 0.03; Figure 1G) and body weight-adjusted NEAT (p= 0.03;
Figure 1H) were higher in the high activity compared to the
moderate activity group.
In the whole sample no correlation was observed between
plasma irisin levels and the number of steps as a measure of
activity (Figure 2A), the amount of METs (Figure 2B) and
other parameters of energy expenditure, namely body weight-
adjusted TEE (Figure 2C), body weight-adjusted REE (Figure 2D),
body weight-adjusted EAT (Figure 2E), and body weight-adjusted
NEAT (Figure 2F).
IRISIN PLASMA LEVELS SHOW A NEGATIVE CORRELATION WITH
COMPONENTS OF ENERGY EXPENDITURE IN PATIENTS WITH
RESTRICTING TYPE ANOREXIA NERVOSA ONLY
After division of the sample into subgroups according to the type
of AN, namely purging type (n= 10), restricting type (n= 20),
and atypical (n= 9) AN, the three groups did not differ in terms
of age and BMI (p> 0.05; Table 1). As shown in Table 1, no differ-
ences among these three groups were observed for irisin, number
of steps per day, METs per day, and the different components of
energy expenditure (p> 0.05).
When investigating the three subgroups separately, irisin levels
showed a negative correlation with the number of steps per day,
duration of exercise, and body weight-adjusted EAT in patients
with restricting type AN (p< 0.05; Table 2), whereas no corre-
lations of plasma irisin and components of energy expenditure
were observed for the subgroups of purging type and atypical AN
(p> 0.05; Table 2).
DISCUSSION
Irisin is a newly defined myokine that increases energy expenditure
by stimulating the expression of UCP1 and thus the browning of
white adipose tissue (1). In addition, it has been shown that irisin
plasma levels are increased in response to different types of exer-
cise (1, 28, 29). Consequently, irisin was proposed to mediate some
of the health-promoting effects of physical activity. In turn, irisin
could be an additional biological mechanism contributing to the
course of the disease and therefore the prognosis in highly active
patients suffering from AN (30, 31). However, in rejection of our
initial hypothesis, we did not detect differences in irisin plasma lev-
els between anorexic patients with high vs. moderate locomotor
activity as determined by average daily step count. When investi-
gating the whole cohort, we also did not observe any correlations
of circulating irisin with physical activity, TEE or other parame-
ters of energy expenditure, in particular EAT. Several points could
contribute to this lack of correlation of irisin with measures of
locomotor activity and energy expenditure in our study.
First, Timmons et al. reported that they failed to detect a strong
increase of the irisin precursor, FNDC5 after exercise in a pop-
ulation of younger adults, whereas only in a subgroup of older
subjects an increase of FNDC5 mRNA expression after exercise
was observed (12). Since our data were collected in a population
of young patients with a mean age of 27, the results could under-
line the hypothesis that exercise-related effects on irisin expression
are associated with age and only (or predominantly) observed in
elderly subjects.
Second, irisin is a cleavage product of FNDC5 expressed mainly
in skeletal muscle. Irisin plasma levels have been shown to be asso-
ciated with biceps circumference as a marker of muscle mass (6,
11). In addition, using bioelectrical impedance analysis (BIA) in a
previous study, we showed a positive correlation of irisin with FFM
and BCM (the measure best reflecting muscle mass using BIA)
(11). Since patients suffering from AN have greatly diminished
muscle mass as a consequence of malnutrition and weight loss,
the total muscle mass might be too low in our patient population
(BCM 15.54± 0.43 kg; FFM 37.02± 0.66 kg) to detect differences
in the levels of the circulating myokine, irisin.
Third, in line with our finding of a lacking association between
energy expenditure and circulating irisin, one recent study did not
detect a correlation of plasma irisin levels with 24-h energy expen-
diture in post-menopausal women when assessed in a metabolic
chamber (13). Subjects in this and our study are in a state of down-
regulated sexual hormones that could contribute to the results.
Another explanation could be that only exercise with respect to a
defined acute or repetitive physical training program exerts signif-
icant effects on irisin muscle expression or plasma levels, whereas
chronic changes in exercise do not. This might be due to counter-
regulatory adaptive changes that have to be further investigated.
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FIGURE 1 | Parameters of energy expenditure in anorexic patients with
moderate and high physical activity. Per definition, the high activity group
showed a higher number of steps compared to the moderate activity group
(A). Irisin levels did not differ between the two groups (B). The metabolic
equivalents per day (C) as well as body weight-adjusted total energy
expenditure (D) were higher in the high compared to the moderate activity
group, while no differences were observed for body weight-adjusted resting
energy expenditure (E). Duration of exercise (F), body weight-adjusted
exercise activity thermogenesis (G), and body weight-adjusted non-exercise
activity thermogenesis (H) were higher in the high compared to the moderate
activity group. Data are expressed as mean±SEM. *p<0.05, **p<0.01,
and ***p<0.001 in the high vs. moderate activity group (n=19/group).
In addition, since irisin has been shown to initiate the browning
of white adipose tissue and thereby eliciting an additional energy-
dissipating effect (1, 3), the existence of a reasonable amount of
beige adipocytes would be crucial to mediate these effects. How-
ever, little is known about the existence of brown and beige adipose
tissue in fat-deprived anorexic subjects. The activity of brown fat
has been reported to be inversely correlated with BMI with reduced
activity in overweight or obese compared to lean young male sub-
jects (4). However, a more recent study did not detect brown fat
activity in anorexic patients, whereas it was detectable in constitu-
tionally lean (average BMI 16.2 kg/m2) subjects (32). The absence
of brown (or beige) fat activity could therefore be another factor
contributing to the lacking correlation of irisin with components
of energy expenditure.
Fourth, parameters of physical activity were measured using
the SenseWear™ armband device shown to be the best esti-
mate of energy expenditure when comparing several monitors
of physical activity in healthy volunteers under regular daily life
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FIGURE 2 | Correlations between circulating irisin concentrations and number of steps per day (A), metabolic equivalents per day (B), body
weight-adjusted total energy expenditure (C), body weight-adjusted resting energy expenditure (D), body weight-adjusted exercise activity
thermogenesis (E), and body weight-adjusted non-exercise activity thermogenesis (F). Values for r and p are indicated in each graph, n=39 patients.
conditions (33). When compared with predictive equations (34),
the SenseWear™ armband device and the doubly labeled water
method have shown sufficient concordance for the assessment of
resting and TEE in healthy volunteers and in overweight subjects
with type 2 diabetes mellitus (35, 36). However, this comparison
is still pending for subjects with reduced body weight. Therefore,
the SenseWear™ armband device might have limitations for the
use in anorexic patients. In addition, the measurement method
of irisin could contribute to the lacking correlation of physical
activity and circulating irisin. Erickson recently commented on
the missing validity of the antibodies used to detect irisin in the
existing studies since a quantitative western blot analysis has not
been conducted yet and thus questioned the results on circulating
irisin published so far (37). However, the antibody by Phoenix
used in the present study seems to be the most suitable to date
since it detects an amino acid sequence that is part of the cleaved
irisin protein (full cross-reactivity with amino acids 42–112 of the
112-amino acid polypeptide irisin, while no cross-reactivity was
observed with the C-terminal parts of the irisin precursor FNDC5
amino acids 149–196 and 162–209, manufacturer’s information).
This contrasts with other antibodies that were raised against the
transmembrane sequence of FNDC5 (1, 8) unlikely to occur in the
circulation.
Lastly, a recent study suggested that the human FNDC5 gene
differs from other species by a mutation in the start codon
sequence (38) which may result in a lower translation efficiency
(39) and consequently could explain difficulties to translate animal
data to humans.
After investigating the whole cohort, we separated the study
population according to the type of anorexia (purging type,
restricting type, and atypical) since there is evidence for differ-
ences in excessive exercise in these subtypes of AN (19, 20, 40,
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Table 1 | Parameters of energy expenditure according to the subtype of anorexia nervosa.
Parameter Group
Purging type AN (n=10) Restricting type AN (n=20) Atypical AN (n=9)
Age (years) 28.6±3.1 27.8±2.4 25.4±1.7
Body mass index (kg/m2) 14.1±0.7 14.3±0.4 15.7±0.6
Irisin (ng/ml) 578.5±41.5 522.8±21.8 536.9±38.6
Number of steps per day 11011±2195 9804±939 9307±1567
METs per day 1.85±0.12 1.83±0.04 1.80±0.08
TEE (kcal/kg/day) 43.7±2.7 43.4±0.9 43.9±2.1
REE (kcal/kg/day) 17.7±0.4 17.9±0.3 18.0±0.2
Duration of exercise (min/day) 17.5±8.9 9.7±2.4 12.4±6.2
EAT (kcal/kg/day) 1.8±1.0 0.9±0.2 1.2±0.6
NEAT (kcal/kg/day) 19.8±1.5 20.3±0.8 20.2±1.7
Data are expressed as mean±SEM, p>0.05. AN, anorexia nervosa; EAT, exercise activity thermogenesis; MET, metabolic equivalent; NEAT, non-exercise activity
thermogenesis; REE, resting energy expenditure; TEE, total energy expenditure.
Table 2 | Correlation of irisin with parameters of energy expenditure according to the subtype of anorexia nervosa.
Parameter Group
Purging type AN (n=10) Restricting type AN (n=20) Atypical AN (n=9)
Number of steps per day r =−0.055; p=0.865 r =−0.465; p=0.039* r =0.283; p=0.434
METs per day r =−0.043; p=0.892 r =−0.171; p=0.464 r =0.332; p=0.356
TEE (kcal/kg/day) r =−0.139; p=0.681 r =−0.251; p=0.280 r =0.333; p=0.356
REE (kcal/kg/day) r =−0.091; p=0.785 r =0.000; p=0.997 r =−0.317; p=0.381
Duration of exercise (min/day) r =−0.006; p=0.973 r =−0.524; p=0.018* r =0.151; p=0.676
EAT (kcal/kg/day) r =−0.018; p=0.946 r =−0.519; p=0.019* r =0.150; p=0.676
NEAT (kcal/kg/day) r =−0.127; p=0.707 r =−0.147; p=0.529 r =0.367; p=0.308
AN, anorexia nervosa; EAT, exercise activity thermogenesis; MET, metabolic equivalent; NEAT, non-exercise activity thermogenesis; REE, resting energy expenditure;
TEE, total energy expenditure. Values for r and p are indicated in each row, *p< 0.05.
41). However, irisin levels and all other parameters of energy
expenditure assessed did not differ between these groups. Simi-
larly to the whole sample, in the subgroups purging and atypical
AN, no correlation was observed between irisin levels and any
parameter of energy expenditure. However, when investigating
the patients with restricting type AN separately, irisin levels neg-
atively correlated with the number of steps per day and body
weight-adjusted EAT which may indicate that this subgroup is a
more homogeneous population of patients. This negative asso-
ciation is unexpected and in contrast to the reported positive
association of exercise and circulating irisin for normal and over-
weight subjects (1, 6, 28). The present finding may point toward a
differential regulation of irisin in patients with restricting type
AN (n= 20) but should be confirmed in a larger cohort of
patients.
In summary, irisin plasma levels do not differ in anorexic
patients with moderate activity from those with high locomotor
activity. Moreover, no association was observed for plasma irisin
levels with various parameters of energy expenditure assessed
under unrestricted conditions of physical activity in hospitalized
patients. Therefore, the current data do not support the concept
of irisin being induced by exercise, at least not under conditions of
severely reduced body weight like AN. Thus, it is also unlikely that
irisin contributes to exceeding energy expenditure in highly active
anorexic patients. Further studies are needed to clarify whether the
lacking correlation of irisin and physical activity described here is
due to a missing association of irisin and exercise under conditions
of reduced body weight per se or because of a unique characteristic
of anorexic patients.
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